首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   67篇
  免费   12篇
  国内免费   1篇
儿科学   2篇
基础医学   8篇
口腔科学   1篇
临床医学   15篇
内科学   10篇
皮肤病学   2篇
神经病学   4篇
特种医学   29篇
外科学   1篇
综合类   2篇
预防医学   1篇
药学   2篇
肿瘤学   3篇
  2022年   1篇
  2018年   2篇
  2017年   1篇
  2015年   1篇
  2014年   3篇
  2013年   4篇
  2012年   1篇
  2011年   4篇
  2010年   1篇
  2009年   3篇
  2008年   5篇
  2007年   1篇
  2005年   1篇
  2004年   2篇
  2002年   1篇
  2001年   2篇
  1998年   3篇
  1997年   4篇
  1995年   2篇
  1994年   2篇
  1993年   1篇
  1989年   3篇
  1988年   4篇
  1987年   2篇
  1986年   3篇
  1985年   4篇
  1984年   5篇
  1983年   2篇
  1982年   3篇
  1981年   2篇
  1979年   1篇
  1977年   3篇
  1976年   2篇
  1941年   1篇
排序方式: 共有80条查询结果,搜索用时 15 毫秒
21.
Periosteal ganglia: CT and MR imaging features   总被引:8,自引:0,他引:8  
  相似文献   
22.
23.
BACKGROUND: This study was undertaken to assess the prevalence of hepatitis C virus (HCV) antibody and RNA in first-time blood donors and to examine the HCV genotype distribution. STUDY DESIGN AND METHODS: A third-generation enzyme-linked immunosorbent assay (ELISA) was used to screen 34,725 donors for HCV antibodies. Donors who were repeatably reactive were tested in two immunoblot assays-a second-generation and a third-generation recombinant immunoblot assay-as well as by a polymerase chain reaction (PCR) assay. PCR-positive donors were genotyped. All samples were screened for alanine aminotransferase levels. RESULTS: The ELISA repeat reactivity rate was 0.55 percent. PCR testing showed that 69 (38%) of the 183 ELISA-reactive samples contained HCV RNA. The third-generation recombinant immunoblot assay identified all 69 viremic samples as antibody positive; however, only 63 tested positive on the second-generation immunoblot. The remaining six PCR-positive donors tested antibody-indeterminate to the core peptide. All six of these donors had HCV subtype 3a infections. Genotype distribution among 58 samples showed that 34 were type 1, of which 22 could be further subtyped as 1a (16) and 1b (6); 2 were 2a; 5 were 2b; and 17 were subtyped as 3a. Donors infected with 2b and 3a had reduced antibody reactivity to the NS4 and NS3 peptides only on the second-generation immunoblot. CONCLUSION: The prevalence of confirmed anti-HCV and viral RNA in new donors is 0.29 and 0.2 percent, respectively. The third-generation recombinant immunoblot assay was more sensitive than the second-generation immunoblot assay in detecting 2b and 3a HCV subtypes. The inclusion of the NS5 peptide in the third- generation recombinant immunoblot did not result in positive tests in any additional donors. Rather, the improvement was due to the increased detection of NS3 and, to a lesser extent, NS4 antibodies. Subtypes 1a and 3a were most prevalent in this population.  相似文献   
24.
25.
异基因造血干细胞移植是治疗滤泡性淋巴瘤的有效方法,大量研究显示接受异基因造血干细胞移植患者的复发率显著低于接受自体造血干细胞移植的患者.非清髓性异基因造血干细胞移植利用其移植物抗淋巴瘤的免疫作用以达到治疗滤泡性淋巴瘤的目的,但是此策略长期的疗效和毒性仍不明确.本项前瞻性研究分析并评价了非清髓性异基因干细胞移植治疗复发的滤泡性淋巴瘤的8年经验.  相似文献   
26.
Genome-wide association scans recently identified common polymorphisms, in intron 1 of FTO and 188 kb downstream MC4R, that modulate body mass index (BMI) and associate with increased risk of obesity. Although their individual contribution to obesity phenotype is modest, their combined effects and their interactions with environmental factors remained to be evaluated in large general populations from birth to adulthood. In the present study, we analyzed independent and combined effects of the FTO rs1421085 and MC4R rs17782313 risk alleles on BMI, fat mass, prevalence and incidence of obesity and subsequent type 2 diabetes (T2D) as well as their interactions with physical activity levels and gender in two European prospective population-based cohorts of 4,762 Finnish adolescents (NFBC 1986) and 3,167 French adults (D.E.S.I.R.). Compared to participants carrying neither FTO nor MC4R risk allele (20–24% of the populations), subjects with three or four risk alleles (7–10% of the populations) had a 3-fold increased susceptibility of developing obesity during childhood. In adults, their combined effects were more modest (~1.8-fold increased risk) and associated with a 1.27% increase in fat mass (P?=?0.001). Prospectively, we demonstrated that each FTO and MC4R risk allele increased obesity and T2D incidences by 24% (P?=?0.02) and 21% (P?=?0.02), respectively. However, the effect on T2D disappeared after adjustment for BMI. The Z-BMI and ponderal index of newborns homozygous for the rs1421085 C allele were 0.1 units (P?=?0.02) and 0.27 g/cm3 (P?=?0.005) higher, respectively, than in those without FTO risk allele. The MC4R rs17782313 C allele was more associated with obesity and fat mass deposition in males than in females (P?=?0.003 and P?=?0.03, respectively) and low physical activity accentuated the effect of the FTO polymorphism on BMI increase and obesity prevalence (P?=?0.008 and P?=?0.01, respectively). In European general populations, the combined effects of common polymorphisms in FTO and MC4R are therefore additive, predictive of obesity and T2D, and may be influenced by interactions with physical activity levels and gender, respectively.  相似文献   
27.
28.
29.
In the previous issue of Critical Care, Dr Bellomo and colleagues reported an observational study of the relationship between nutritional intake and survival in the RENAL randomized controlled trial. In summary, the total energy intake in a very large and severely ill patient population was low. Higher average daily caloric energy intake was not associated with improved survival. The study illustrates the complexity of the interaction between disease and nutrition.  相似文献   
30.
McNeely  GF; Dickhaus  AJ; Colella  JP; Hawkins  IF  Jr 《Radiology》1986,161(1):274-275
A needle guide was used to create a fistula from an obstructed common bile duct to the duodenum in a patient with a large tumor of the head of the pancreas. The tortuosity and severity of the stricture prevented the use of routine guide wire passage. A 5-F hyperalimentation catheter was also placed, in addition to the biliary drainage stent.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号